Aptevo Therapeutics (APVO) Stock Chart & Stock Price History → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free APVO Stock Alerts $1.03 -0.13 (-11.21%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Aptevo Therapeutics Stock Price Performance5 Day Performance+4.15%1 Month Performance-72.31%3 Month Performance-84.08%6 Month Performance-90.21%Year-To-Date Performance-87.07%1 Year Performance-98.61% Receive APVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> APVO Stock Chart for Wednesday, May, 8, 2024 APVO Chart by TradingView Aptevo Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$1.11$1.16+4.50%$1.19$1.03573,340 shs$499,000.0005/06/2024$0.99$1.11+12.23%$1.14$1.00819,073 shs$477,000.0005/03/2024$1.13$0.99-12.48%$1.09$0.961.97 million shs$425,000.0005/02/2024$0.96$1.13+17.71%$1.38$1.0425.93 million shs$486,000.0005/01/2024$0.71$0.96+35.08%$1.14$0.735.77 million shs$413,000.0004/30/2024$0.75$0.71-5.23%$0.75$0.71114,155 shs$306,000.00 Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.71$0.75+6.20%$0.77$0.72447,804 shs$322,000.0004/26/2024$0.68$0.71+3.84%$0.72$0.68170,019 shs$304,000.0004/25/2024$0.68$0.68-0.38%$0.71$0.67367,850 shs$292,000.0004/24/2024$0.74$0.68-7.28%$0.75$0.68567,282 shs$294,000.0004/23/2024$0.71$0.74+3.69%$0.76$0.70358,578 shs$317,000.0004/22/2024$0.73$0.71-2.39%$0.72$0.67164,644 shs$305,000.0004/19/2024$0.77$0.73-5.53%$0.77$0.71229,798 shs$313,000.0004/18/2024$0.71$0.77+8.07%$0.77$0.71227,360 shs$331,000.0004/17/2024$0.77$0.71-7.23%$0.78$0.70412,322 shs$306,000.0004/16/2024$0.78$0.77-1.92%$0.80$0.75551,370 shs$329,000.0004/15/2024$0.85$0.78-7.35%$0.85$0.76465,918 shs$337,000.0004/12/2024$0.96$0.85-11.78%$0.93$0.83784,516 shs$363,000.0004/11/2024$2.40$0.96-60.08%$1.06$0.934.66 million shs$412,000.0004/10/2024$3.26$2.40-26.38%$3.10$2.21711,867 shs$1.03 million04/09/2024$3.72$3.26-12.37%$3.78$3.25378,561 shs$1.40 million04/08/2024$3.63$3.72+2.48%$4.87$3.44696,455 shs$1.60 million04/05/2024$3.44$3.63+5.52%$4.25$3.28432,401 shs$1.56 million04/04/2024$3.80$3.44-9.47%$3.82$3.3544,067 shs$1.48 million04/03/2024$3.98$3.80-4.52%$4.10$3.6254,667 shs$1.63 million04/02/2024$4.25$3.98-6.35%$4.46$3.8059,090 shs$1.71 million04/01/2024$4.69$4.25-9.38%$4.68$4.1082,244 shs$1.83 million03/29/2024$4.69$4.69$5.00$3.95304,555 shs$2.02 million03/28/2024$4.06$4.69+15.52%$5.00$3.95293,949 shs$2.02 million03/27/2024$4.01$4.06+1.25%$4.10$3.9028,957 shs$1.75 million03/26/2024$4.01$4.01$4.09$3.8123,996 shs$1.72 million03/25/2024$4.56$4.01-12.06%$4.59$3.9876,338 shs$1.72 million03/22/2024$4.48$4.56+1.79%$4.83$4.4436,608 shs$1.96 million03/21/2024$5.14$4.48-12.84%$5.04$4.47154,149 shs$1.93 million03/20/2024$5.03$5.14+2.19%$5.50$4.9998,334 shs$2.21 million03/19/2024$4.98$5.03+1.00%$5.36$4.9871,291 shs$2.16 million03/18/2024$5.42$4.98-8.12%$5.60$4.8082,932 shs$2.14 million03/15/2024$5.04$5.42+7.54%$5.59$4.93138,599 shs$2.33 million03/14/2024$4.96$5.04+1.61%$5.14$4.55108,171 shs$2.17 million03/13/2024$4.07$4.96+21.87%$5.66$4.25311,044 shs$2.13 million“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free.03/12/2024$4.40$4.07-7.50%$4.60$4.05104,546 shs$1.74 million03/11/2024$5.19$4.40-15.22%$5.32$4.35203,333 shs$1.89 million03/08/2024$6.60$5.19-21.36%$6.49$5.12254,762 shs$2.23 million03/07/2024$6.40$6.60+3.12%$10.80$6.353.63 million shs$124.34 million03/06/2024$5.69$6.40+12.41%$6.75$5.35160,240 shs$120.58 million03/05/2024$6.23$5.69-8.55%$6.41$5.5025,066 shs$2.44 million03/04/2024$7.22$6.23-13.72%$6.81$5.7243,379 shs$2.67 million03/01/2024$7.48$7.22-3.53%$7.48$6.7410,489 shs$3.09 million02/29/2024$6.85$7.48+9.18%$7.92$6.6431,749 shs$3.20 million02/28/2024$6.55$6.85+4.57%$7.48$6.6022,950 shs$2.93 million02/27/2024$6.34$6.55+3.40%$6.82$5.907,096 shs$2.81 million02/26/2024$5.94$6.34+6.67%$6.42$6.043,830 shs$2.71 million02/23/2024$6.12$5.94-2.88%$6.47$5.5010,621 shs$2.54 million02/22/2024$6.38$6.12-4.14%$6.60$5.986,270 shs$2.62 million02/21/2024$6.34$6.38+0.69%$6.72$6.345,600 shs$2.73 million02/20/2024$6.73$6.34-5.82%$6.82$6.169,506 shs$2.71 million02/19/2024$6.73$6.73$6.97$6.603,725 shs$2.88 million02/16/2024$6.91$6.73-2.61%$6.97$6.603,723 shs$2.88 million02/15/2024$6.64$6.91+3.97%$7.00$6.384,015 shs$2.96 million02/14/2024$6.68$6.64-0.59%$7.04$6.494,919 shs$2.85 million02/13/2024$6.78$6.68-1.36%$7.04$6.437,151 shs$2.86 million02/12/2024$6.89$6.78-1.60%$7.04$6.606,527 shs$2.90 million02/09/2024$6.47$6.89+6.46%$7.10$6.318,664 shs$2.95 million02/08/2024$6.73$6.47-3.92%$7.04$6.406,062 shs$2.77 million02/07/2024$6.79$6.73-0.91%$7.11$6.608,530 shs$2.88 million Related Companies: AMPE Stock Price Chart ATHX Stock Price Chart SXTC Stock Price Chart CALA Stock Price Chart ADTX Stock Price Chart BLPH Stock Price Chart EVFM Stock Price Chart SBFM Stock Price Chart EVLO Stock Price Chart SPRC Stock Price Chart Receive APVO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APVO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.